Smith & Nephew plc (LON:SN)
1,133.50
-4.50 (-0.40%)
May 26, 2026, 5:01 PM GMT
Smith & Nephew Revenue
In the year 2025, Smith & Nephew had annual revenue of $6.16B USD with 6.09% growth. Smith & Nephew had revenue of $3.20B in the half year ending December 31, 2025, with 13.78% growth.
Revenue
$6.16B
Revenue Growth
+6.09%
P/S Ratio
2.11
Revenue / Employee
$362.84K
Employees
16,988
Market Cap
9.68B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16B | 354.00M | 6.09% |
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
| Dec 31, 2018 | 4.90B | 139.00M | 2.92% |
| Dec 31, 2017 | 4.77B | 96.00M | 2.06% |
| Dec 31, 2016 | 4.67B | 35.00M | 0.76% |
| Dec 31, 2015 | 4.63B | 17.00M | 0.37% |
| Dec 31, 2014 | 4.62B | 266.00M | 6.11% |
| Dec 31, 2013 | 4.35B | 214.00M | 5.17% |
| Dec 31, 2012 | 4.14B | -133.00M | -3.11% |
| Dec 31, 2011 | 4.27B | 308.00M | 7.77% |
| Dec 31, 2010 | 3.96B | 190.00M | 5.04% |
| Dec 31, 2009 | 3.77B | -29.00M | -0.76% |
| Dec 31, 2008 | 3.80B | 432.00M | 12.82% |
| Dec 31, 2007 | 3.37B | 590.00M | 21.23% |
| Dec 31, 2006 | 2.78B | 227.00M | 8.89% |
| Dec 31, 2005 | 2.55B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Hikma Pharmaceuticals | 2.49B |
| Convatec Group | 1.81B |
| Spire Healthcare Group | 1.58B |
| CVS Group | 692.80M |
| Genus | 672.00M |
Smith & Nephew News
- 1 day ago - Smith & Nephew price target lowered to 1,550 GBp at Goldman Sachs - TheFly
- 15 days ago - Smith & Nephew price target lowered to $30 from $32 at Canaccord - TheFly
- 15 days ago - Smith & Nephew price target lowered to $31.85 from $36.20 at Bernstein - TheFly
- 18 days ago - Cevian Capital II GP LTD Acquires Significant Stake in Smith & Nephew PLC - GuruFocus
- 18 days ago - Smith & Nephew and Four More Stocks See Action From Activist Investors - Barron's
- 18 days ago - Smith & Nephew To Repurchase Up To $250 Mln Of Shares - Nasdaq
- 19 days ago - Smith & Nephew price target raised to 1,350 GBp from 1,300 GBp at Barclays - TheFly
- 20 days ago - Smith & Nephew Earnings Call Transcript: Q1 2026 - Transcripts